Your browser doesn't support javascript.
loading
Building the Evidence for Systemic Treatment in Desmoid Fibromatosis: Is a New Metronomic Regimen Another Layer in the Foundation?
Alcindor, Thierry.
Affiliation
  • Alcindor T; Center for Sarcoma, Center for Global Cancer Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
JCO Glob Oncol ; 10: e2300488, 2024 May.
Article in En | MEDLINE | ID: mdl-38723215
ABSTRACT
@Thalcin explains how a metronomic regimen for desmoid tumors fits in the current treatment landscape.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibromatosis, Aggressive / Administration, Metronomic Limits: Humans Language: En Journal: JCO Glob Oncol / JCO global oncology Year: 2024 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibromatosis, Aggressive / Administration, Metronomic Limits: Humans Language: En Journal: JCO Glob Oncol / JCO global oncology Year: 2024 Document type: Article Country of publication: Estados Unidos